A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adults

Preprint, not peer reviewed. Levy-Cooperman N, Sellers E, Glue P et al.. medRxiv, 19 Jul 2026.

Tags: Human, RCT, Preprint, Psilocybin, Anxiety.